Archive for 'Biopharmacy'

Bone Therapeutics completes a €7.7 Million Series D Fundraising round to further advance ongoing PREOB® Phase III clinical trials

Bone Therapeutics completes a €7.7 Million Series D Fundraising round to further advance ongoing PREOB® Phase III clinical trials

Following the approval of the pivotal phase III osteonecrosis trial of PREOB® last November (posted Nov. 9, 2012), Bone Therapeutics has just completed a €7.7 million Series D fundraising round. Of the raised funds, €6.1 million were [...]

DNAlytics welcomes new customers after receiving official “UCL spin-off” label and support from the Caring Entrepreneurship Fund.

DNAlytics welcomes new customers after receiving official “UCL spin-off” label and support from the Caring Entrepreneurship Fund.

Founded in April 2012 by Prof. Pierre Dupont and Dr. Thibault Helleputte, privately held company DNAlytics(Louvain-la-Neuve, Belgium) has recently become a new spin-off of the Université Catholique de Louvain (UCL). During the summer of 2012 a [...]